๐Ÿ‡ฐ๐Ÿ‡ฟ Country Profile

Kazakhstan

Medicine from India reaching Kazakhstan

๐Ÿ‡ฐ๐Ÿ‡ฟ $89.0M
All data from DGCIS India export records (fiscal year, Aprilโ€“March).
$89.0M
Scale
Kazakhstan's patients receive $89.0M in Indian pharmaceutical products annually โ€” almost entirely finished medicines ready for dispensing.
83%
Medicine
Overwhelmingly finished medicines โ€” drug formulations account for 83% of shipments.
1.7ร—
Trajectory
India's pharmaceutical supply to Kazakhstan has grown 1.7ร— over the past decade โ€” strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Europe.
โœฆ
Impact
Indian pharmaceutical companies have both exported to and invested directly in Kazakhstan โ€” building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix — FY 2025–26 DGCIS
Medicines $74.3M (83.5%) Traditional & Herbal $8.1M (9.1%) Vaccines $3.5M (3.9%) Medicine Ingredients $1.6M (1.8%) Surgical & Hospital Supplies $1.6M (1.8%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Kazakhstan Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Kazakhstan: $9.2M across 7 filings (2012-2025).